Transcranial focused ultrasound stimulation of motor cortical areas in freely-moving awake rats.
Authors: Lee W, Croce P, Margolin RW, Cammalleri A, Yoon K, Yoo SS
Low-intensity transcranial focused ultrasound (tFUS) has emerged as a new non-invasive modality of brain stimulation with the potential for high spatial selectivity and penetration depth. Anesthesia is typically applied in animal-based tFUS brain stimulation models; however, the type and depth of anesthesia are known to introduce variability in responsiveness to the stimulation. Therefore, the ability to conduct sonication experiments on awake small animals, such as rats, is warranted to avoid confounding effects of anesthesia. We developed a miniature tFUS headgear, operating at 600 kHz, which can be attached to the skull of Sprague-Dawley rats through an implanted pedestal, allowing the ultrasound to be transcranially delivered to motor cortical areas of unanesthetized freely-moving rats. Video recordings were obtained to monitor physical responses from the rat during acoustic brain stimulation. The stimulation elicited body movements from various areas, such as the tail, limbs, and whiskers. Movement of the head, including chewing behavior, was also observed. When compared to the light ketamine/xylazine and isoflurane anesthetic conditions, the response rate increased while the latency to stimulation decreased in the awake condition. The individual variability in response rates was smaller during the awake condition compared to the anesthetic conditions. Our analysis of latency distribution of responses also suggested possible presence of acoustic startle responses mixed with stimulation-related physical movement. Post-tFUS monitoring of animal behaviors and histological analysis performed on the brain did not reveal any abnormalities after the repeated tFUS sessions. The wearable miniature tFUS configuration allowed for the stimulation of motor cortical areas in rats and elicited sonication-related movements under both awake and anesthetized conditions. The awake condition yielded diverse physical responses compared to those reported in existing literatures. The ability to conduct an experiment in freely-moving awake animals can be gainfully used to investigate the effects of acoustic neuromodulation free from the confounding effects of anesthesia, thus, may serve as a translational platform to large animals and humans.
Introduction
Purpose
Transcranial ultrasound stimulation
Study Objective
To develop and validate a miniature wearable transcranial focused ultrasound headgear for stimulating motor cortical areas in awake, freely-moving rats and compare evoked responses to those under anesthesia.
Animal model / Human subject
Sprague–Dawley rat (Charles River), age not reported, sex: male
Disease model
healthy
MRI or image guidance method
Stereotactic (coordinates referenced to skull landmarks — bregma, lambda, aural meatus — via a surgically implanted skull pedestal; acoustic focus aligned to motor cortex using transducer geometry and a rat motor cortex functional atlas)
Targeted brain region(s)
Motor Cortex
Target coordinates
Not provided
Cargo name and characteristics
Not Provided
Route of administration
intraperitoneal (i.p.) for ketamine/xylazine; inhalation for isoflurane
Outcomes and Safety
Summary of Outcomes
A wearable 600 kHz transcranial focused ultrasound device evoked motor responses (tail, limbs, whiskers, head movements and chewing) in freely-moving rats with higher response rates, shorter latencies and lower inter-animal variability when awake versus under ketamine/xylazine or isoflurane, and effective sonication parameters included intensities at or above ~3.4 ± 1.8 W/cm2 I_sppa in awake animals (thresholds ~10.2 ± 2.4 W/cm2 I_sppa for ketamine/xylazine and ~12.4 ± 2.8 W/cm2 I_sppa for isoflurane), with tested maxima up to 14.9 W/cm2 I_sppa (≈7.5 W/cm2 I_spta, peak rarefaction ≈0.67 MPa, MI ≈0.86) and inter-stimulus intervals ≥5 s, without histological damage.
Duration of biological effect
≈400 ms
Safety-related matter
No adverse effects were observed: animals showed normal behavior after repeated tFUS and histological analyses (H&E, VAF-toluidine blue, GFAP, caspase-3) and BBB tests revealed no damage, with an estimated thermal rise of only ~0.016°C. However, the authors note that a prior higher-intensity study showed hemosiderin (possible bleeding), and that sonication parameters (intensity/MI) lack consensus for brain safety and require further study.
Brain Region
Ultrasound Parameters
Ultrasound instrument
function generator (33210A; Agilent, Santa Clara, CA) and amplified by a class-A linear amplifier (240 L; Electronics and Innovations Ltd., Rochester, NY)
FUS Frequency
600 kHz
FUS Intensity
2.1 W/cm^2
FUS Mode
pulsed
Pulse duration
300ms
Duration of a single FUS session
Approximately 48–93 s
Focal Characteristics
10 mm
Treatment frequency
Multiple sessions
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search